Related Experiment Video
Updated: May 29, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
The renin-angiotensin-aldosterone system and glucose homeostasis
James Matthew Luther1, Nancy J Brown
1Vanderbilt University Medical Center, Nashville, TN 37232-2358, USA. james.luther@vanderbilt.edu
Abstract:
The renin-angiotensin-aldosterone system (RAAS) is inappropriately activated in obesity. In individuals at risk for diabetes, RAAS inhibition protects against kidney and heart disease, and also reduces the incidence of diabetes in large clinical trials. At a cellular level, angiotensin II (Ang II) and aldosterone induce insulin resistance by increasing oxidative stress and altering insulin signaling, leading to decreased glucose transport. Ang II also contributes to oxidative stress, inflammation, and apoptosis in pancreatic β cells. Aldosterone diminishes glucose-stimulated insulin secretion in vivo and in vitro from isolated pancreatic islets and cultured β cells through a mineralocorticoid receptor (MR)-independent mechanism. We review these findings in the context of pharmacological strategies interrupting the RAAS to highlight the potential application of these strategies to the prevention of diabetes progression.
Insights
The renin-angiotensin-aldosterone system (RAAS) activation in obesity promotes insulin resistance and diabetes. RAAS inhibition may prevent diabetes progression by mitigating these effects.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cardiovascular Physiology
Background:
- The renin-angiotensin-aldosterone system (RAAS) is implicated in obesity-related metabolic dysfunction.
- RAAS activation is linked to insulin resistance, kidney disease, and cardiovascular complications.
- Inhibition of RAAS has shown promise in preventing diabetes incidence in clinical trials.
Purpose of the Study:
- To review the cellular mechanisms by which RAAS components contribute to insulin resistance and pancreatic beta-cell dysfunction.
- To explore the potential of pharmacological RAAS inhibition for preventing diabetes progression.
Main Methods:
- Review of existing literature on RAAS, obesity, insulin resistance, and diabetes.
- Analysis of cellular and molecular pathways affected by angiotensin II and aldosterone.
- Examination of clinical trial data on RAAS inhibitors and diabetes incidence.
Main Results:
- Angiotensin II and aldosterone induce insulin resistance via oxidative stress and impaired insulin signaling.
- Angiotensin II promotes oxidative stress, inflammation, and apoptosis in pancreatic beta cells.
- Aldosterone impairs glucose-stimulated insulin secretion through a mineralocorticoid receptor-independent pathway.
Conclusions:
- RAAS blockade represents a potential therapeutic strategy for preventing diabetes progression in at-risk individuals.
- Understanding RAAS-mediated cellular damage is crucial for developing targeted interventions.
- Pharmacological interruption of RAAS may offer a dual benefit in managing obesity-related comorbidities and preventing diabetes.
Related Concept Videos
Hormonal Regulation
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hypertension II: Pathophysiology

